Summary

Overview

Work History

Education

Skills

Clinical Rotations

Research

Timeline

Sheila Zermeno

Pembroke Pines,FL

Summary

Accomplished Radiologic Technologist with over 12 years' experience seeking to secure a position with a respected organization. Highly skilled in producing high quality diagnostic images, comforting patients and delivering clinical instruction to staff and students. Demonstrated leadership skills which guide teams towards success and strengthen relationships with patients and physicians.

Overview

years of professional experience

Work History

X-Ray Tech/MRI Tech

Joe Dimaggio Children's Hospital

Hollywood, FL

05.2023 - Current

Performed radiographic exams on patients of all ages in accordance with established protocols.
Provided patient education and instructions prior to radiographic procedures.
Utilized radiation safety techniques to protect the patient, staff, and self from radiation exposure.
Assisted physicians with radiological imaging studies such as MRI's, ultrasound and fluoroscopy.
Operated X-ray equipment to produce radiographs of designated body parts for diagnostic purposes.
Evaluated images for technical quality and consistency with physician orders.
Reviewed patient history and prepared patients for Radiologic exams using immobilization devices when necessary.
Ensured that all paperwork was completed accurately before releasing the patient from care.
Set up rooms for specific procedures according to protocol requirements.
Verified patient information including name, medical record number, date of birth., prior to performing any procedure and examination.
Monitored patients during examinations and ensured their comfort at all times.
Maintained a clean work environment by adhering to infection control policies and procedures.
Collaborated effectively with other healthcare professionals in order to provide exceptional patient care.
Demonstrated strong communication skills while interacting with patients and families throughout the entire process.
Participated in continuing education courses related to Radiology technology.
Adhered strictly to HIPAA regulations regarding privacy of protected health information.

X-Ray Tech/MA/MRI Tech/Joint Assessor/Office Supervisor

Integral Rheumatology & Immunology Specialists

Plantation, FL

03.2014 - 04.2023

Managed a team of 30 medical office staff, including hiring and training new employees.
Monitored patient flow in the office to ensure efficient scheduling of appointments.
Conducted weekly meetings with staff to discuss performance goals, objectives, and challenges.
Reviewed patient records for accuracy and completeness prior to submission for billing purposes.
Oversaw daily operations of the medical office, including handling customer inquiries and complaints.
Managed inventory of medical supplies and equipment, ensuring adequate stock levels at all times.
Ensured proper coding of diagnosis and services provided by physicians for insurance reimbursement purposes.
Processed payroll information for all medical office personnel using an automated system.
Analyzed current practices within the medical office to identify areas of improvement or potential cost savings opportunities.
Resolved conflicts among staff members in a timely manner while maintaining professional standards.
Provided exceptional patient experience through friendly and compassionate communications.
Scheduled appointments, oversaw check-ins and resolved patient concerns in high-volume rheumatology practice.
Collaborated with interdisciplinary teams to ensure that all client assessments were completed accurately and and timely.
oversee the flow of the office in seeing over 100 patients daily
organizing company events and conferences, booking accommodations for the providers travels
attending meetings with senior management, manage contract and price negotiations with office vendors, service providers and office lease
interview and manage onboarding process of new hires, work with account receivables and budget

X-ray Tech/Medical Assistant

South Florida Institute of Sports Medicine

Pembroke Pines , FL

10.2009 - 03.2014

Assisted physicians with patient care by taking vital signs, patient histories and preparing patients for examinations.
Administered injections, medications and treatments as directed by the physician.
Provided assistance to medical staff in performing minor surgical procedures.
Removed and applied casts
removed stitches
assisted providers with minor surgeries in office
Maintained accurate medical records through filing, charting, transcription and data entry into electronic health record system.
Answered phones, scheduled appointments and managed patient flow while greeting visitors in a professional manner.
Assisted with pre-operative preparation of patients including providing instruction about post-operative care plans.
Ensured that all instruments used during exams were cleaned properly after each use according to established protocols.
Kept examination rooms clean, stocked with necessary supplies and prepared for incoming patients.
Measured vital signs and took medical histories to prepare patients for examination.
Interviewed and engaged patients to obtain medical history, chief complaints and vital signs.
Relayed messages from patients to physicians about concerns, condition updates or refill requests to facilitate treatment.

Education

Bachelor of Science - Psychology

Nova Southeastern University

Davie, FL

08-2015

Associate of Applied Science - X-ray Technologist

Broward College

Fort Lauderdale, FL

06-2009

Combat Medic

US Army Reserves

06-2008

Skills

Independent Joint Count Assessor
Diagnostic Imaging
Medical Records Management
CPR/BLS Certified
NIDA Good Clinical Practice Certification
Clinical Photography

X-rays
Patient Assessments
Radiation safety
HIPAA Compliance
Staff Education
Patient Care

Clinical Rotations

North Broward Hospital (01/09-06/09) - XRAY
Memorial West Hospital (01/08-08/08) - XRAY
Memorial Regional Hospital (08/07-12/07) - XRAY
Dadeland MRI (2018)- MRI

Research

1. A multicenter, randomized, double-blinded, placebo-controlled, parallel group study of CNTO136 (sirukumab), a human anti-IL-6 monoclonal antibody, administered subcutaneously, in subjects with active rheumatoid arthritis despite anti-TNF therapy.

2. A multicenter, parallel-group study of long-term safety and efficacy of CNTO136 (sirukumab) for rheumatoid arthritis in subjects completing treatment in studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T).

3. A multicenter, randomized, double-blinded, placebo-controlled, parallel group study of CNTO136 (sirukumab) administered subcutaneously as monotherapy compared with adalimumab monotherapy, in subjects with active rheumatoid arthritis.

4. A phase 3, randomized, double-blind, placebo-controlled, study of the efficacy and safety of 2 doses of tofacitinib (CP-690,550) in subjects with active psoriatic arthritis and an inadequate response to at least one TNF inhibitor.

5. A phase 3, randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of tofacitinib (CP-690,550) or adalimumab in subjects with active psoriatic arthritis.

6. A long term, open label extension study of tofacitinib (CP-690,550) for the treatment of psoriatic arthritis.

7. A randomized, double-blind, placebo-and active-controlled, phase 3 study evaluating the efficacy and safety of baricitinib in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate and therapy.

8. A randomized, double-blind, placebo-and active-controlled, phase 3 study evaluating the efficacy and safety of baricitinib (LY3009104) in patients with moderately to severely active rheumatoid arthritis who have had limited or no treatment with disease-modifying antirheumatic drugs.

9. A phase 3, multicenter study to evaluate the long-term safety and efficacy of baricitinib in patients with rheumatoid arthritis.

10. A randomized, double-blinded, placebo-controlled, phase-2 study to investigate the safety and efficacy of ABT-494 given with methotrexate (MTX) in subjects with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or tolerance to anti-TNF biologic therapy.

11. Phase 2 study, multicenter, open-label extension (OLE) study in rheumatoid arthritis subjects who have completed a preceding phase 2 randomized controlled trial (RCT) with ABT-494.

12. A phase 2A, 4-week, double-blind, proof-of-concept efficacy and safety study of CC-292 vs. placebo as co-therapy with methotrexate in active rheumatoid arthritis.

13. Gs-Us-417-0301-In Patients With Rheumatoid Arthritis. "Finch 1". Gilead/Galapagos

14. Gs-Us-417-0302-In Patients With Rheumatoid Arthritis. "Finch 2". Gilead/Galapagos

15. Gs-Us-417-0303-In Patients With Rheumatoid Arthritis. "Finch 3". Gilead/Galapagos

16. Gs-Us-417-0304-In Patients With Rheumatoid Arthritis. "Finch 4". Gilead/Galapagos

17. Im006-016- In Patients With Rheumatoid Arthritis. Bristol-Myers Squibb (Bms)

18. Cain457fus01- In Patients With Psoriatic Arthritis. Novartis

19. M13-538- In Patients with rheumatoid arthritis who have completed a preceding phase 2 Rct with Abt-494. Open-label extension study "balance". Abbvie

20. Ms200527-0018- In patients with systemic lupus erthyematosus (Sle) "Btki-Sle". Emd Serono Research & Development Institute, Inc.

21. M16-063- A phase 2 study to investigate the safety and efficacy of Abbv-105 given alone or in combination with Upadacitinib (Abbv-599 combination) with a background of conventional synthetic dmards in subjects with active rheumatoid arthritis with inadequate response or intolerance to biologic dmards.

22. M15-998- A phase 3, randomized, double-blind study comparing Isankizumab to placebo in subjects with active psoriatic arthritis including those who have a history of inadequate response or intolerance to biologic therapy (LES).

23. M16-011- A phase 3, randomized, double-blind, study comparing Isankizumabto placebo in subjects with active psoriatic arthritis (Psa) who have a history of inadequate response to or intolerance to at least one disease modifying anti-rheumatic drug (Dmard) therapy.

24. M16-852- Giant cell arteritis: Phase 3 safety and efficacy study of Upadacitinib in subjects with Giant Cell Arteritis.

25. I4v-Mc-Jaia- A randomized, double-blind, placebo-controlled, parallel-group, phase 3 study of Baricitinib in patients with systemic lupus erythematosus.

26. I4v-Mc-Jaja- A randomized, active-controlled, parallel-group, phase 3b/4 study of baricitinib in patients with rheumatoid arthritis.

27. M19-130- A phase 2 study to investigate the safety and efficacy of Abbv-105 and Upadacitinib given alone or in combination (Abbv-599 combination) in subjects with moderately to severely active systemic lupus erythematosus.

28. As0006-Phase 3, multicenter, randomized, placebo-controlled,double-blind study to evaluate efficacy and safety of certolizumab pegol in subjects with active axial spondyloarthritis (Axspa) without xray evidence of ankylosing spondylitis (As) and objective signs of inflammation.

29 . Im101-567- A randomized, head to head, single-blinded study to assess changes in the immune profile in response to treatment with subcutaneous abatacept in combination with methotrexate vs. subcutaneous adalimumab in combination with methotrexate in adults with early rheumatoid arthritis who are naive to biologic disease-modifying antirheumatic drugs.

30. Im014-029- A randomized, placebo-controlled, double-blind, multicenter study to assess the efficacy and safety of Branebrutinib treatment in subjects with active systemic lupus erythematosus or primary sjogren's syndrome, and Branebrutinib treatment alone and in combination with Abatacept in subjects with active rheumatoid arthritis.